Ian H. Nielsen
Arhus, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Multiparametric Optimization of Human Primary B-Cell Cultures Using Design of Experiments.
Journal: Scandinavian journal of immunology
Published: January 20, 2025
Characterization of TLR9 responsiveness in cell subsets derived from in vitro pDC differentiation of hematopoietic stem and progenitor cells.
Journal: Frontiers in immunology
Published: December 23, 2024
Cell-targeted gene modification by delivery of CRISPR-Cas9 ribonucleoprotein complexes in pseudotyped lentivirus-derived nanoparticles.
Journal: Molecular therapy. Nucleic acids
Published: May 22, 2024
Exploiting FcRn engagement of an albumin-CpG oligonucleotide covalent conjugate for potent TLR9 immune induction.
Journal: The Journal of biological chemistry
Published: January 27, 2024
Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR/Cas ribonucleoprotein complexes supporting base editing, prime editing and in vivo gene modification.
Journal: Nucleic acids research
Published: May 19, 2023
Impaired STING Activation Due to a Variant in the E3 Ubiquitin Ligase AMFR in a Patient with Severe VZV Infection and Hemophagocytic Lymphohistiocytosis.
Journal: Journal of clinical immunology
Published: May 12, 2023
Resistance to vincristine in DLBCL by disruption of p53-induced cell cycle arrest and apoptosis mediated by KIF18B and USP28.
Journal: British journal of haematology
Published: February 14, 2023
Showing 1-8 of 8
Last Updated: 09/26/2026